PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL) | Zendy

Fowler N. H. | Zendy; Dickinson M. | Zendy; MartinezLopez J. | Zendy; Kolstad A. | Zendy; Schuster S. J. | Zendy; Dreyling M. | Zendy; Ghosh M. | Zendy; Harigae H. | Zendy; Kersten M. José | Zendy; Bachy E. | Zendy; Popplewell L. | Zendy; Chavez J. C. | Zendy; Ho P. J. | Zendy; Butler J. | Zendy; Kato K. | Zendy; Tresckow B. | Zendy; Ferreri A. J. M. | Zendy; Simón J. A. P. | Zendy; Patten P. E. M. | Zendy; Andreadis C. | Zendy; Riedell P. A. | Zendy; McGuirk J. P. | Zendy; Nastoupil L. J. | Zendy; Teshima T. | Zendy; Offner F. | Zendy; Petzer A. | Zendy; Viardot A. | Zendy; Zinzani P. L. | Zendy; Malladi R. | Zendy; Zhang J. | Zendy; Tiwari R. | Zendy; Bollu V. | Zendy; Masood A. | Zendy; Thieblemont C. | Zendy

Premium

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

Author(s) -

Fowler N. H.,

Dickinson M.,

MartinezLopez J.,

Kolstad A.,

Schuster S. J.,

Dreyling M.,

Ghosh M.,

Harigae H.,

Kersten M. José,

Bachy E.,

Popplewell L.,

Chavez J. C.,

Ho P. J.,

Butler J.,

Kato K.,

Tresckow B.,

Ferreri A. J. M.,

Simón J. A. P.,

Patten P. E. M.,

Andreadis C.,

Riedell P. A.,

McGuirk J. P.,

Nastoupil L. J.,

Teshima T.,

Offner F.,

Petzer A.,

Viardot A.,

Zinzani P. L.,

Malladi R.,

Zhang J.,

Tiwari R.,

Bollu V.,

Masood A.,

Thieblemont C.

Publication year - 2021

Publication title -

hematological oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.918

H-Index - 44

eISSN - 1099-1069

pISSN - 0278-0232

DOI - 10.1002/hon.178_2880

Subject(s) - refractory (planetary science) , medicine , follicular lymphoma , quality of life (healthcare) , oncology , lymphoma , materials science , metallurgy , nursing

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research